Mechanism of T cell exhaustion in a chronic environment

키워드

참고문헌 (83)

1. Badovinac, V. P, "CD8(+) T-cell homeostasis after infection: setting the 'curve'", icrobes Infect, 4, pp.441~447 (2002)
2. Kaech, S. M, "Molecular and functional profiling of memory CD8 T cell differentiation", Cell, 111, pp.837~851 (2002)
3. Lechner, F, "Analysis of successful immune responses in persons infected with hepatitis C virus", J. Exp. Med, 191, pp.1499~1512 (2000)
4. Mongkolsapaya, J, "Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever", Nat. Med, 9, pp.921~927 (2003)
5. Van Epps, H. L, "Long-lived memory T lymphocyte responses after hantavirus infection", J. Exp. Med, 196, pp.579~588 (2002)
6. Wherry, E. J, "Memory CD8 T-cell differentiation during viral infection", J. Virol, 78, pp.5535~5545 (2004)
7. Kaech, S. M, "Effector and memory T-cell differentiation: implications for vaccine development", Nat. Rev. Immunol, 2, pp.251~262 (2002)
8. Schluns, K. S, "Cytokine control of memory T-cell development and survival", Nat. Rev. Immunol, 3, pp.269~279 (2003)
9. Klenerman, P, "T cells and viral persistence: lessons from diverse infections", Nat. Immunol, 6, pp.873~879 (2005)
10. Anichini, A, "The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma", Cancer Immunol. Immunother, 53, pp.855~864 (2004)
11. den Boer, A. T, "The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environment", J. Immunol, 172, pp.6074~6079 (2004)
12. Zippelius, A, "Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance", Cancer Res, 64, pp.2865~2873 (2004)
13. Coussens, L. M, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)
14. Virgin, H. W, "Redefining chronic viral infection", Cell, 138, pp.30~50 (2009)
15. Zajac, A. J, "Viral immune evasion due to persistence of activated T cells without effector function", J. Exp. Med, 188, pp.2205~2213 (1998)
16. Crawford, A, "The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses", Curr. Opin. Immunol, 21, pp.179~186 (2009)
17. Wherry, E. J, "Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment", J. Virol, 77, pp.4911~4927 (2003)
18. Wherry, E. J, "Molecular signature of CD8+ T cell exhaustion during chronic viral infection", Immunity, 27, pp.670~684 (2007)
19. Shin, H, "CD8 T cell dysfunction during chronic viral infection", Curr. Opin. Immunol, 19, pp.408~415 (2007)
20. Shin, H, "Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection", J. Exp. Med, 204, pp.941~949 (2007)
21. Mumprecht, S, "Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression", Blood, 114, pp.1528~1536 (2009)
22. Fourcade, J, "Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients", J. Exp. Med, 207, pp.2175~2186 (2010)
23. Ahmadzadeh, M, "Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired", Blood, 114, pp.1537~1544 (2009)
24. Barber, D. L, "Restoring function in exhausted CD8 T cells during chronic viral infection", Nature, 439, pp.682~687 (2006)
25. Sharpe, A. H, "The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection", Nat. Immunol, 8, pp.239~245 (2007)
26. Jin, H. T, "Role of PD-1 in Regulating T-Cell Immunity", Curr. Top. Microbiol. Immunol (2010)
27. Ha, S. J, "Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection", Journal Of Experimental Medicine, 205(3), pp.543~555 (2008)
28. Boni, C, "Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection", J. Virol, 81, pp.4215~4225 (2007)
29. Day, C. L, "PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression", Nature, 443, pp.350~354 (2006)
30. Freeman, G. J, "Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade", J. Exp. Med, 203, pp.2223~2227 (2006)
31. Petrovas, C, "PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection", J. Exp. Med, 203, pp.2281~2292 (2006)
32. Radziewicz, H, "Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression", J. Virol, 81, pp.2545~2553 (2007)
33. Trautmann, L, "Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction", Nat. Med, 12, pp.1198~1202 (2006)
34. Urbani, S, "PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion", J. Virol, 80, pp.11398~11403 (2006)
35. Velu, V, "Enhancing SIV-specific immunity in vivo by PD-1 blockade", Nature, 458, pp.206~210 (2009)
36. D'Souza, M, "Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction", J. Immunol, 179, pp.1979~1987 (2007)
37. Golden-Mason, L, "Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction", J. Virol, 81, pp.9249~9258 (2007)
38. Hamanishi, J, "Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer", Proc. Natl. Acad. Sci. U.S.A, 104, pp.3360~3365 (2007)
39. Hino, R, "Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma", Cancer, 116, pp.1757~1766 (2010)
40. Nakanishi, J, "Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers", Cancer Immunol. Immunother, 56, pp.1173~1182 (2007)
41. Nomi, T, "Clinical significance and therapeutic potential of the programmed death-1 ligand", programmed death-1 pathway in human pancreatic cancer, 2007, pp.13, 2151~2157
42. Ohigashi, Y, "Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand- 2 expression in human esophageal cancer", Clin. Cancer Res, 11, pp.2947~2953 (2005)
43. Thompson, R. H, "Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target", Proc. Natl. Acad. Sci. U.S.A, 101, pp.17174~17179 (2004)
44. Wu, C, "Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance", Acta Histochem, 108, pp.19~24 (2006)
45. Fourcade, J, "PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients", J. Immunol, 182, pp.5240~5249 (2009)
46. Brahmer, J. R, "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates", J. Clin. Oncol, 28, pp.3167~3175 (2010)
47. Berger, R, "Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies", Clin. Cancer Res, 14, pp.3044~3051 (2008)
48. Blackburn, S. D, "Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection", Nat. Immunol, 10, pp.29~37 (2009)
49. Golden-Mason, L, "Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells", J. Virol, 83, pp.9122~9130 (2009)
50. 하상준, "Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(33), pp.14733~14738, National Academy of Sciences
51. Jones, R. B, "Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection", J. Exp. Med, 205, pp.2763~2779 (2008)
52. Sakuishi, K, "Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity", J. Exp. Med, 207, pp.2187~2194 (2010)
53. Shin, H, "A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection", Immunity, 31, pp.309~320 (2009)
54. Agnellini, P, "Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection", Proc. Natl. Acad. Sci. U.S.A, 104, pp.4565~4570 (2007)
55. Quigley, M, "Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF", Nat. Med, 16, pp.1147~1151 (2010)
56. Pellegrini, M, "IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology", Cell, 144, pp.601~613 (2011)
57. Abbas, A. K, "Dendritic cells giveth and taketh away", Nat. Immunol, 6, pp.227~228 (2005)
58. Lore, K, "Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection", AIDS, 16, pp.683~692 (2002)
59. Redpath, S, "Immune checkpoints in viral latency", Annu. Rev. Microbiol, 55, pp.531~560 (2001)
60. Tortorella, D, "Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology", Immunol. Invest, 29, pp.97~100 (2000)
61. Fuller, M. J, "Ablation of CD8 and CD4 T cell responses by high viral loads", J. Immunol, 170, pp.477~486 (2003)
62. Moskophidis, D, "Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells", Nature, 362, pp.758~761 (1993)
63. Mueller, S. N, "High antigen levels are the cause of T cell exhaustion during chronic viral infection", Proc. Natl. Acad. Sci. U.S.A, 106, pp.8623~8628 (2009)
64. Schacker, T. W, "Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection", Clin. Vaccine Immunol, 13, pp.556~560 (2006)
65. Mueller, S. N, "Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection", Proc. Natl. Acad. Sci. U.S.A, 104, pp.15430~15435 (2007)
66. Zhang, M, "Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells", Nat. Immunol, 5, pp.1124~1133 (2004)
67. Svensson, M, "Stromal cells direct local differentiation of regulatory dendritic cells", Immunity, 21, pp.805~816 (2004)
68. Benedict, C. A, "Specific remodeling of splenic architecture by cytomegalovirus", PLoS Pathog, 2, pp.e16~ (2006)
69. Donaghy, H, "Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load", Blood, 98, pp.2574~2576 (2001)
70. Pacanowski, J, "Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection", Blood, 98, pp.3016~3021 (2001)
71. Kanto, T, "Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection", J. Infect. Dis, 190, pp.1919~1626 (2004)
72. Smed-Sorensen, A, "Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells", J. Virol, 79, pp.8861~8869 (2005)
73. Lore, K, "Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigenspecific CD4+ T cells", J. Exp. Med, 201, pp.2023~2033 (2005)
74. Schmitt, N, "Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection", AIDS, 20, pp.533~542 (2006)
75. Cameron, P. U, "Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes", J. Virol, 81, pp.2297~2306 (2007)
76. Groot, F, "Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition", Blood, 108, pp.1957~1964 (2006)
77. Cavaleiro, R, "Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease", PLoS Pathog, 5, pp.e1000667~ (2009)
78. Blackburn, S. D, "Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion", J. Virol, 84, pp.2078~2089 (2010)
79. Sevilla, N, "Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells", J. Exp. Med, 192, pp.1249~1260 (2000)
80. Sevilla, N, "Infection of dendritic cells by lymphocytic choriomeningitis virus", Curr. Top. Microbiol. Immunol, 276, pp.125~144 (2003)
81. Homann, D, "Visualizing the viral burden: phenotypic and functional alterations of T cells and APCs during persistent infection", J. Immunol, 172, pp.6239~6250 (2004)
82. Sevilla, N, "Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion", J. Clin. Invest, 113, pp.737~745 (2004)
83. Wang, X, "B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection", Eur. J. Immunol, 38, pp.3226~3236 (2008)